Citations 458

The Diagnosis and Understanding of Apraxia of Speech: Why Including Neurodegenerative Etiologies May Be Important

Journal of Speech, Language, and Hearing Research | October 1, 2012 | Volume: 55 | Issue: 5 | Pages: No page available

10.1044/1092-4388(2012/11-0309) | PMID 23033445

Purpose To discuss apraxia of speech (AOS) as it occurs in neurodegenerative disease (progressive AOS [PAOS]) and how its careful study may contribute to general concepts of AOS and help refine its diagnostic criteria. Method The article summarizes our current understanding of the clinical features and neuroanatomical and pathologic correlates of PAOS and its relationship to primary progressive aphasia (PPA). It addresses similarities and differences between PAOS and stroke-induced AOS that may be relevant to improving our understanding of AOS in general. Conclusions PAOS is clinical disorder that should be distinguished from PPA. Its recognition is important to clinical care provided by speech-language pathologists, but it also has implications for neurologic localization and diagnosis as well as prediction of underlying pathology and histochemistry. The clinical features of PAOS and stroke-induced AOS have not been explicitly compared, but they may not be identical because PAOS does not follow a vascular distribution, the brunt of cortical pathology is in the premotor and supplementary motor area, and its onset (rather than acute) is slowly progressive with potential for adaptation to gradual impairment. Careful description and study of PAOS may be a valuable source of information for refining our understanding of AOS in general.
TMEM106B risk variant is implicated in the pathologic presentation of Alzheimer disease

Neurology | August 2, 2012 | Volume: 79 | Issue: 7 | Pages: 717-718

10.1212/wnl.0b013e318264e3ac | PMID 22855871

MRI characteristics and scoring in HDLS due to CSF1R gene mutations

Neurology | July 27, 2012 | Volume: 79 | Issue: 6 | Pages: 566-574

10.1212/wnl.0b013e318263575a | PMID 22843259

Fluorodeoxyglucose F18 PET in progressive emotional dysprosody

Neurology | July 20, 2012 | Volume: 79 | Issue: 5 | Pages: 480-481

10.1212/wnl.0b013e31826170e0 | PMID 22815548

IC‐P‐113: Microbleeds in logopenic progressive aphasia

Alzheimer's & Dementia | July 19, 2012 | Volume: 8 | Issue: 4S_Part_2 | Pages: No page available

10.1016/j.jalz.2012.05.147

P4‐165: Microbleeds in logopenic progressive aphasia

Alzheimer's & Dementia | July 19, 2012 | Volume: 8 | Issue: 4S_Part_19 | Pages: No page available

10.1016/j.jalz.2012.05.1869

P1‐152: MRI in pathologically‐defined hippocampal sparing and limbic predominant atypical variants of Alzheimer's disease

Alzheimer's & Dementia | July 19, 2012 | Volume: 8 | Issue: 4S_Part_4 | Pages: No page available

10.1016/j.jalz.2012.05.430

IC‐O2IC‐05: MRI in pathologically defined hippocampal sparing and limbic predominant atypical variants of Alzheimer's disease

Alzheimer's & Dementia | July 19, 2012 | Volume: 8 | Issue: 4S_Part_1 | Pages: No page available

10.1016/j.jalz.2012.05.027

O1‐05‐06: Characterization of frontotemporal dementia +/‐ amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72

Alzheimer's & Dementia | July 19, 2012 | Volume: 8 | Issue: 4S_Part_3 | Pages: No page available

10.1016/j.jalz.2012.05.2129

P1‐173: A kindred with familial frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72

Alzheimer's & Dementia | July 19, 2012 | Volume: 8 | Issue: 4S_Part_5 | Pages: No page available

10.1016/j.jalz.2012.05.451